Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04802876
Title Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors (ACROPOLI)
Acronym ACROPOLI
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Ico Badalona Badalona Barcelona 08916 Spain Details
ICO Hospitalet L'Hospitalet De Llobregat Barcelona Spain Details
Hospital Universitari Sant Joan de Reus Reus Tarragona 43204 Spain Details
IOB - H. Quironsalud Barcelona Barcelona 08023 Spain Details
Hospital Vall Hebron Barcelona 08035 Spain Details
Hospital Clinic Barcelona Barcelona 08036 Spain Details
Hospital Universitario Basurto Bilbao Spain Details
Complejo Asistencial Universitario de León León 24001 Spain Details
Fundación Jiménez Díaz Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Virgen del Rocío Sevilla Spain Details
Instituto Valenciano de Oncología (IVO) Valencia 46009 Spain Details
Hospital Clínico Universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field